Novo Integrated Sciences, Inc.
NVOS · OTC
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | |
|---|---|---|---|---|
| Revenue | $3,081 | $3,152 | $3,171 | $3,891 |
| % Growth | -2.3% | -0.6% | -18.5% | – |
| Cost of Goods Sold | $1,503 | $2,255 | $1,847 | $1,947 |
| Gross Profit | $1,578 | $897 | $1,324 | $1,944 |
| % Margin | 51.2% | 28.5% | 41.8% | 50% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,511 | $3,414 | $2,861 | $5,252 |
| SG&A Expenses | $2,514 | $3,417 | $2,864 | $5,262 |
| Sales & Mktg Exp. | $2 | $3 | $3 | $10 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,514 | $3,417 | $2,864 | $5,262 |
| Operating Income | -$936 | -$2,520 | -$1,540 | -$3,318 |
| % Margin | -30.4% | -80% | -48.6% | -85.3% |
| Other Income/Exp. Net | $5,950 | -$11,216 | -$1,206 | -$1,343 |
| Pre-Tax Income | $5,014 | -$13,736 | -$2,746 | -$4,661 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $5,002 | -$13,742 | -$2,746 | -$4,680 |
| % Margin | 162.4% | -436% | -86.6% | -120.3% |
| EPS | 0.26 | -0.74 | -0.16 | -0.28 |
| % Growth | 135.1% | -362.5% | 42.9% | – |
| EPS Diluted | 0.26 | -0.74 | -0.16 | -0.28 |
| Weighted Avg Shares Out | 19,055 | 18,686 | 17,643 | 16,726 |
| Weighted Avg Shares Out Dil | 19,055 | 18,686 | 17,643 | 16,726 |
| Supplemental Information | – | – | – | – |
| Interest Income | $196 | $2 | $2 | $2 |
| Interest Expense | $1,671 | $3,083 | $1,253 | $1,219 |
| Depreciation & Amortization | $564 | $557 | $568 | $572 |
| EBITDA | $7,250 | -$10,096 | -$924 | -$2,869 |
| % Margin | 235.3% | -320.3% | -29.1% | -73.7% |